首页 › 基金 › Opaleye Management Inc. › NTLA
Opaleye Management Inc. 对 NTLA 的持仓历史
INTELLIA THERAPEUTICS INC · 医疗保健
Opaleye Management Inc. 在 Q2 2026 的 13F 申报中披露持有 NTLA(INTELLIA THERAPEUTICS INC)250,000 股,市值约 US$4.2M,约占其申报组合的 0.38%,在其申报持仓中市值排名第 38 位。 Opaleye Management Inc. 最近 11 个申报季度中有 5 个季度披露了 NTLA 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Opaleye Management Inc. 对 NTLA 的持仓演变
Opaleye Management Inc. 于 Q4 2023 首次披露 NTLA 持仓:99,000 股(约 US$3.0M)。 该持仓在 Q1 2024 达到峰值 255,000 股,市值约 US$7.0M。 在 5 次申报中,Opaleye Management Inc. 2 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 250,000 股、市值约 US$4.2M,环比增持 5,000 股。。 持仓曾出现大幅变动:Q1 2024 增持约 158% (随后一个季度股价下跌 19%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 99.00K | $3.02M | 新进 |
| Q1 2024 | 255.00K | $7.02M | 增持 |
| Q2 2024 | 218.00K | $4.88M | 减持 |
| Q1 2026 | 245.00K | $3.14M | 新进 |
| Q2 2026 | 250.00K | $4.23M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NTLA 与 13F 数据
NTLA(INTELLIA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 39 只申报持有 NTLA,申报仓位最大的包括:方舟投资 (US$285.5M), RA CAPITAL MANAGEMENT, L.P. (US$76.6M), REGENERON PHARMACEUTICALS, INC. (US$62.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NTLA 的基金
- 方舟投资 16.88M 股 · $285.54M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 4.53M 股 · $76.60M · Q2 2026
- REGENERON PHARMACEUTICALS, INC. 3.70M 股 · $62.65M · Q2 2026
- Amova Asset Management Americas, Inc. 2.90M 股 · $49.03M · Q2 2026
- Contrarius Group Holdings Ltd 1.96M 股 · $33.08M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.50M 股 · $25.38M · Q2 2026
- Ghisallo Capital Management LLC 1.20M 股 · $20.30M · Q2 2026
- IQ EQ FUND MANAGEMENT (IRELAND) Ltd 777.95K 股 · $13.16M · Q2 2026
更多关于 Opaleye Management Inc.
常见问题
How long has Opaleye Management Inc. held NTLA?
Opaleye Management Inc. has disclosed NTLA holdings in 5 of the last 11 reported quarters, going back to Q4 2023.
What is Opaleye Management Inc.'s current position in NTLA?
As of Q2 2026, Opaleye Management Inc. holds 250.00K shares of NTLA (INTELLIA THERAPEUTICS INC), valued at $4.23M, representing 0.38% of its reported portfolio and ranking #38.
Has Opaleye Management Inc. been buying or selling NTLA?
In the latest 13F filing (Q2 2026), Opaleye Management Inc. increased its position in NTLA. The position peaked in Q1 2024 at 255.00K shares.
Which other funds hold NTLA?
Other major institutional holders of NTLA include 方舟投资, RA CAPITAL MANAGEMENT, L.P., REGENERON PHARMACEUTICALS, INC., among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.